Nephrology

ERSD, heart disease and African-Americans with hypertensive nephrosclerosis

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD). According to research being presented at...

Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with...

Background Vascular access (VA) dysfunction is a major clinical complication in the hemodialysis population and has a direct effect on dialysis outcome. This study was conducted to explore the role of microinflammation in the...

Nephrologist Donald W. Landry, M.D., Ph.D. to Chair Medicine

Donald W. Landry, M.D., Ph.D., a national leader in forging organic chemical solutions to intractable medical problems has been named chairman of the Department of Medicine at the Columbia University College of Physicians and...

NxStage Applauds Array of Studies To Be Presented at American Society of Nephrology Meeting

LAWRENCE, Mass., Nov. 5 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced that the annual scientific meeting of the American Society of Nephrology (ASN)...

Gap found in kidney disease treatment for aboriginal Canadians

Aboriginal Canadians with chronic kidney disease may be twice as likely to be admitted to hospital for a potentially preventable condition compared with non-aboriginal people, researchers have found. In Tuesday's issue of the...

Specialists / Consultants WalkIn Interview by SAIL at Bhilai

STEEL AUTHORITY OF INDIA LIMITED (A Government of India Enterprise) BHILAI STEEL PLANT Bhilai – 490 001, Chhattisgarh WALK-IN-INTERVIEW FOR SPECIALISTS /CONSULTANTS The JLN Hospital & Research Center (JLNHRC), Bhilai Steel...

Pervasis Therapeutics to Present Data from Phase 1 and 2 Clinical Trials of Vascugel at the...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 30, 2008 - Pervasis Therapeutics, Inc., a biotechnology company pioneering biologically active therapies and devices to treat serious illnesses, today announced that data from the...

Pervasis Therapeutics To Present Data From Phase 1 And 2 Clinical Trials Of Vascugel® At The ASN...

Pervasis Therapeutics, Inc., a biotechnology company pioneering biologically active therapies and devices to treat serious illnesses, today announced that data from the company's Phase 1 and Phase 2 trials of Vascugel® V-HEALTH...

Recipient Of Halpin Foundation-ASN Research Grant Anounced By The Halpin Foundation And The ASN

The Halpin Foundation and the American Society of Nephrology (ASN) proudly announce the recipient of the Halpin Foundation-ASN Research Grant for 2008, which was created to provide funding for young faculty to foster evolution...

Satellite Healthcare Will Present at the American Society of Nephrology's Renal Week - Booth 527

Satellite Healthcare, Inc., one of the nation's first and largest providers of kidney dialysis services and a major sponsor of nephrology research, today announced that its chief researchers will present at the American Society...